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Objective:Conflicting data exist regarding the effect of chronic renal insufficiency (CRI) on carotid endarterectomy (CEA)
outcomes. A large database was used to analyze the effect of CRI, defined by glomerular filtration rate (GFR), as an
independent risk factor of CEA.
Methods: Prospectively collected data regarding CEAs performed at 123 Veterans Affairs Medical Centers as part of the
National Surgical Quality Improvement Program were retrospectively analyzed. Renal function was used to divide
patients into three CRI groups: normal or mild (control; GFR >60 mL/min/1.73 m2), moderate (GFR 30 to 59), and
severe (GFR <30). Bivariate analysis and multivariate logistic regression were used to characterize risk factors and their
associations with 30-day morbidity and mortality.
Results: Between Jan 1, 1996, and Dec 31, 2003, 22,080 patients underwent CEA. Patients missing creatinine levels,
already dialysis-dependent, or in acute renal failure just before surgery were excluded. This left 20,899 available for
analysis, of which 13,965 had a GFR of >60, 6,423 had a GFR of 30 to 59, and 511 had a GFR of <30. The incidence
of neurologic complications did not differ significantly (control, 1.7%; moderate CRI, 1.9%; severe CRI, 2.7%). The
moderate CRI group experienced significantly more cardiac events (1.7% vs 0.9% for controls, P < .001). This remained
predictive in the multivariate model even adjusting for all other risk factors (adjusted odds ratio [AOR], 1.6; 95%
confidence interval [CI], 1.1-2.3; P .009). The moderate CRI group also had higher rates of pulmonary complications
(2.1% vs 1.3% control; P< .001; AOR, 1.3; 95% CI, 1.0-1.7; P .031) but not 30-day mortality (P .269). Those with
severe CRI had a much higher mortality (3.1% vs 1.0% control, P< .001), which remained significant in the multivariate
model (AOR, 2.7; 95% CI, 1.6-4.8; P < .001).
Conclusion: Although impaired renal function does not independently increase the risk of neurologic or infectious
complications, CRI is a significant negative independent risk factor in predicting other outcomes after CEA. Patients with
moderate CRI (GFR, 30-59mL/min/1.73m2) are at increased risk for cardiac and pulmonary morbidity, but not death,
and those with severe CRI (GFR <30 mL/min/1.73 m2) have a much higher operative mortality. Patients with CRI
should be carefully evaluated before CEA to optimize existing cardiac and pulmonary disease. Understanding this increased
risk may assist the surgeon in preoperative counseling and perioperative management. (J Vasc Surg 2008;48:1423-30.)Stroke has been a leading cause of serious long-term
disability and remains the third major cause of death in the
United States even apart fromother cardiovascular diseases.1,2
Landmark trials such as the North American Symptomatic
Carotid Endarterectomy Trial (NASCET), Asymptomatic
Carotid Atherosclerosis Study (ACAS), and European Ca-
rotid Surgery Trial (ECST) demonstrated that in select
patients with carotid stenosis, carotid endarterectomy
(CEA) reduced the risk of ipsilateral stroke compared with
best medical management.3-5
Since then, attempts have been made to identify char-
acteristics that make certain patients high-risk for CEA.6-13
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Vascular Surgery.doi:10.1016/j.jvs.2008.07.006Best medical management has undergone significant im-
provements with the use of -blockers, statins, and anti-
platelet agents. Determining the risk of poor outcome after
CEA in individual patients is confounded by many factors,
especially comorbidities.
Chronic renal insufficiency (CRI) is one risk factor that
has been related to poor outcomes after CEA.14-20 Previ-
ously published studies on this topic divided patients based
on serum creatinine levels and arrived at mixed conclu-
sions.5,7-9,11,13-21 An explanation of the disparate results is
that creatinine is a late and insensitive marker, which can
remain 2.0 mg/dL despite a significant reduction of the
glomerular filtration rate (GFR) to as low as 15 mL/min/
1.73 m2.22 The inaccuracy of estimation of creatinine of
total renal function is due to various factors; the National
Kidney Foundation’s Kidney Disease Outcome Quality
Initiative (NKF KDOQI) guidelines recommend the use of
GFR as a better early indicator of chronic kidney dis-
ease.22-24
Accordingly, it is possible that operative risks in patients
with CRI have not been well estimated to date. Our objec-
tive was to analyze renal insufficiency by GFR as an inde-
pendent risk factor that has a negative effect on outcomes of
CEA using a large multicenter database.
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Database. The Veterans Affairs National Surgical
Quality Improvement Program (VA-NSQIP) is an ongoing
quality management initiative that has been used in other
outcome analysis studies. The VA-NSQIP prospectively
collects quality improvement data on all operations per-
formed at 123 participating VA medical centers in the
United States.25 Baseline clinical and demographic charac-
teristics, operation and anesthesia information, and postop-
erative complication data are recorded by trained nurse
reviewers from medical record review, surgeon interview,
or patient follow-up, or both. Deaths are reported and
verified against the VA Beneficiary Identification and
Records Locator System (BIRLS) death records.
Sample selection. We queried the VA-NSQIP for all
surgical encounters between Jan 1, 1996, and Dec 31,
2003, identified by the Current Procedural Terminology
code 35301. All patients returned by the query were ini-
tially considered for analysis. We excluded individuals who
were missing recorded serum creatinine levels, who presented
in acute renal failure just before operation, or who were
already dialysis-dependent. Institutional Review Board ap-
proval was obtained. All patient information was stripped of
identifiers and sent to the principal investigator in a secure
fashion using file encryption and password protection.
Postoperative outcomes. Primary outcomes of inter-
est were the development of one or more postoperative
complications or death30 days after surgery, or both. We
grouped complications into the following categories: neu-
rologic, defined as a new cerebrovascular accident/stroke
or coma lasting 24 hours; cardiac, defined as myocardial
infarction or cardiac arrest; pulmonary, defined as failure to
wean from the ventilator 48 hours or any unplanned
reintubation; and infectious, defined as sepsis, urinary tract
infection, or pneumonia.
Determination of renal function. In our database
the serum creatinine concentration most closely preceding
surgery was available for almost all patients. The abbrevi-
ated Modification of Diet in Renal Disease (MDRD) equa-
tion26 was used to calculate GFR based on creatinine (Cr),
age, gender, and race: GFR (mL/min/1.73 m2)  186 
(Cr)–1.154  (Age)–0.203  (0.742 if female)  (1.210 if
African American).
We categorized patients into those with normal or
mildly reduced renal function (GFR 60 mL/min/1.73
m2), moderate renal insufficiency (GFR 30-59 mL/min/
1.73 m2), severe renal insufficiency (GFR 30 mL/min/
1.73m2), and dialysis-dependent renal failure.We included
patients with GFR 15 mL/min/1.73 m2 in the severe
renal insufficiency group as long as they were not yet
actually dialysis-dependent.
These categorizations were based on the NKF KDOQI,
which provides evidence-based clinical practice guidelines for
all stages of chronic kidney disease and related complica-
tions.24Within these guidelines, all individualswithGFR60
mL/min/1.73 m2 for 3 months are classified as having
chronic kidney disease, because this represents loss of at leasthalf of normal adult kidney function. Though the KDOQI
Work Group initially defined the above categories of severity
arbitrarily, evidence compiled in later guidelines supports
these cutoff levels.
Baseline patient demographic, comorbid, and oper-
ative characteristics. Various other risk factors were ana-
lyzed in addition to renal function. Patient demographics
included age, sex, and race. Existing comorbidities in-
cluded previous stroke/cerebrovascular accident, transient
ischemic attacks (TIA), congestive heart failure (CHF),
chronic obstructive pulmonary disease (COPD), diabetes
mellitus (none or diet-controlled vs those requiring oral
medications or insulin), American Society of Anesthesiolo-
gists (ASA) classification, and functional status. Neurologic
symptoms were considered present if a patient had a history
of stroke or TIA before CEA.
Preoperative functional status is defined in the VA-
NSQIP as the level of self-care demonstrated 30 days
before surgery. This is based on activities of daily living such
as bathing, feeding, dressing, toileting, and walking. Pa-
tients were considered independent if they did not require
assistance of nursing care, equipment, or devices.
History of cigarette smoking was quantified in pack-
years and was considered current if the patient smoked 1
year of the operation. Current alcohol abuse was defined as
the consumption of2 drinks per day in the 2 weeks before
surgery.
Basic operative characteristics were recorded, such as
type of anesthesia used and duration of the operation.
Preoperative laboratory values were also included on most
patients, including serum albumin, hematocrit, white
blood cell (WBC) count, platelet count, prothrombin time,
partial thromboplastin time, and creatinine, sodium, and
serum urea nitrogen levels.
Statistical analysis. Bivariate analyses were performed
considering each of the risk factors, such as renal function,
comorbidities, laboratory values, and operative informa-
tion, against each outcome category. The Fisher exact test
or the 2 test was used for categoric variables, and two-
tailed analysis of variance (ANOVA) was used for continu-
ous variables. All values of P  .05 were considered signif-
icant. If the ANOVA test was significant, a post hoc
Bonferroni test was used.
For multivariate analysis, all risk factors were included
in stepwise logistic regressionmodels (with hierarchicmod-
eling to account for clustering at the institutional level) that
were generated for each outcome of interest. An entry
criterion of P  .25 and exit/significance criterion of P 
.05 were used to identify independent predictors. Final
models were checked for goodness-of-fit using pseudo R2
and Hosmer-Lemeshow tests. Analyses were completed
using Stata 8.0 software (StataCorp LP, College Station,
Tex).
RESULTS
We identified 22,080 patients who underwent CEA
during the 8-year study period, of which 1070weremissing
creatinine data, 76 were already dialysis-dependent, and 35
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these, 20,899 subjects were available for complete analysis.
Characteristics of the three renal function groups are out-
lined in Table I. Those with CRI were statistically more
likely to be older, diabetic, of higher ASA category, and
have other medical problems like CHF and COPD. They
were also more likely to abuse alcohol and nicotine, and
have poor functional status. Serum albumin, hematocrit,
and platelet counts were lower—and prothrombin time was
Table I. Summary of relevant baseline patient demograph
Variable GFR 
Patients, No. 13,96
Age, mean (SD), y 66.7 (8
Male, % 9
White, non-Hispanic, % 8
History of TIA, % 3
History of stroke, %
Without deficits, %
With deficits, % 1
CHF (1 month pre-op), %
COPD (%) 1
Diabetes mellitus, %
Oral agent 1
Insulin, %
Smokers, % 4
Alcohol use, % 1
Poor functional status, %
ASA, mean (SD), class 3.06 (0
Preoperative levels
Albumin, mean (SD), mg/dL 3.96 (0
WBC, mean (SD), 1000 cells/mL 7.78 (2
Hematocrit, mean (SD), % 41.5 (4
Platelets, mean (SD), U 234 (7
PT, mean (SD), s 12.5 (2
ASA, American Association of Anesthesiologists; CHF, congestive heart fail
glomerular filtration rate; PT, prothrombin time; TIA, transient ischemic a
aDefined according to the estimated GFR in mL/min/1.73m2. All statistical
bP  .001, analysis of variance.
cP  .001, 2 test.
dP  .05, 2 test.
eP  .01, analysis of variance.
Table II. Incidence of complications after carotid
endarterectomy by level of renal functiona according to
univariate analysis
Complication
GFR 60
(n  13,965), %
GFR 30-59
(n  6,423), %
GFR 30
(n  511), %
Neurologic 1.7 1.9 2.7
Cardiac 0.9 1.7b 1.0
Pulmonary 1.3 2.1b 3.1b
Infectious 1.5 2.4b 4.5b
Death 30 days 1.0 1.4c 3.1b
aDefined by estimated glomerular filtration rate (GFR) in mL/min/1.73
m2. All statistical comparisons are made to the control group (GFR 60) as
the reference category.
bP .001, 2 test.
cP  .05, 2 test.higher—as renal function worsened.There were 373 (1.8%) neurologic complications in all.
The rate of stroke or coma was 1.7% in patients with normal
or mildly depressed renal function, 1.9% in those with
moderate CRI, and 2.7% in those with severe CRI. Al-
though initially appearing to be higher in the severe CRI
group, these differences were not statistically significant on
bivariate (Table II) or multivariate (Fig, Table III) analysis.
Significant risk factors included diabetes, either controlled
by oral medications (odds ratio [OR], 1.3; 95% confidence
0
0.5
1
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2
2.5
3
3.5
4
4.5
5
Neurologic Cardiac Pulmonary Infectious Mortality
%
GFR ≥ 60
GFR 30-59
GFR < 30
* 
* 
* 
Fig. Incidence of postoperative complications after carotid endar-
terectomy. *Comparisons with GFR 60 mL/min/1.73 m2,
statistical significance in multivariate model, any P .05, see Table
III.
y renal functiona
GFR 30-59 GFR 30
6423 511
71.5 (7.3)b 71.9 (7.1)b
98.4 98.2
84.8b 80.2
31.9 32.3
10.0c 9.6
18.5 20.9
4.1b 5.7b
17.0d 17.6
18.1c 18.6d
12.5b 18.0b
31.0b 29.4b
5.7b 5.3
7.1 8.8d
3.12 (0.45)b 3.23 (0.47)b
3.90 (0.45)b 3.72 (0.53)b
7.79 (2.59) 7.82 (2.32)
39.9 (4.8)b 36.2 (5.2)b
225 (68.9)b 223 (77.2)e
12.6 (1.7)e 12.8 (1.8)
OPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; GFR,
WBC, white blood cells.
arisons are made to the control group (GFR60) as the reference category.ics, b
60
5
.7)
8.7
0.6
3.1
8.8
9.1
2.0
5.8
7.3
8.2
4.1
0.0
6.6
.45)
.45)
.53)
.4)
0.9)
.1)
ure; C
ttack;
compinterval [CI], 1.0-1.7; P  .04) or insulin (OR, 1.5; 95%
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1.5-2.3; P  .001), previous stroke (OR, 1.9; 95% CI,
1.5-2.4; P  .001), and dependent functional status (OR,
1.8; 95% CI, 1.3-2.4; P  .001).
A total of 245 patients (1.2%) experienced a postoper-
ative cardiac complication. Cardiac occurrences were al-
most twice as frequent in the moderate CRI group than in
the control group (1.7% vs 0.9%), which was statistically
significant (P  .001). After the multivariate analysis was
adjusted for the other significant risk factors, moderate CRI
remained predictive. In the multivariate model, the ad-
justed OR (AOR) was 1.6 (95% CI, 1.1-2.3; P  .009).
The rate of cardiac complications in the severe CRI group
was 1.0%, which was not significantly different than in the
control group.
Pulmonary complications (324, 1.5% overall) were
more frequent in groups with moderate CRI (2.1%, P 
.001) and severe CRI (3.1%, P .001) compared with the
control group (1.3%). The use of general anesthesia, pres-
ence of diabetes mellitus, history of COPD, history of TIA
or stroke, poor functional status, smoking, and ASA class 4
were also significantly associated with increased pulmonary
complications on bivariate analysis. After adjustment in the
multivariate model, moderate CRI (GFR 30-59 mL/min/
1.73m2) was independently predictive (AOR, 1.3; 95% CI,
1.0-1.7; P  .031), but severe CRI was not.
There were 384 (1.8%) infectious complications, of
which there was a graduated association with worsening
renal function (GFR 60 mL/min/1.73 m2, 1.5%; GFR
30-59 mL/min/1.73 m2, 2.4%; and GFR 30 mL/min/
1.73 m2, 4.5%; P  .001). Older age and dependent
functional status were also significant on bivariate analysis;
however, after adjustment, these two factors alone were
predictive in the multivariate model but degree of CRI was
Table III. Multivariate analysis of postoperative
complications and death by renal function category
Complication AORa 95% CI P
GFR 60b Ref Ref Ref
Neurologic
GFR 30-59 1.1 0.8-1.3 .652
GFR 30 1.5 0.9-2.6 .124
Cardiac
GFR 30-59 1.6 1.1-2.3 .009
GFR 30 0.6 0.2-2.1 .458
Pulmonary
GFR 30-59 1.3 1.0-1.7 .031
GFR 30 1.6 0.9-2.9 .105
Infectious
GFR 30-59 0.9 0.7-1.2 .664
GFR 30 1.9 1.0-4.0 .068
Death
GFR 30-59 1.2 0.9-1.7 .269
GFR 30 2.7 1.6-4.8 .001
AOR, Adjusted odds ratio; CI, confidence interval; GFR, glomerular filtra-
tion rate.
aRelative to a value of 1.00 for reference category with bestimated GFR60
mL/min/1.73m2.not.Overall, 249 patients (1.2%) died within 30 days of CEA.
In the control group, operative mortality was 1.0%, consis-
tent with previous reports. The risk was significantly in-
creased in moderate CRI patients (1.4%, P  .048) and
much higher in the severe CRI group (3.1%, P  .001).
Other significant factors included history of stroke, CHF,
poor functional status, ASA class 3, and WBC count
12,000 cells/mL. After adjusting for other risk factors,
GFR30 mL/min/1.73 m2 remained independently pre-
dictive of death (AOR, 2.7; 95% CI, 1.6-4.8; P  .001),
along with history of stroke, CHF, poor functional status,
and ASA class 3.
Poorer outcomes in symptomatic vs asymptomatic
carotid stenosis. About 50% (10,497) of the operations in
our data set were performed in patients who had neurologic
symptoms before CEA. Negative outcomes were almost
twice as common in the symptomatic group than in the
asymptomatic group across all categories except cardiac
complications (Table IV). In the multivariate analysis, a
history of stroke or TIA before CEA was an independent
predictor of increased neurologic events (AOR, 2.1; 95%
CI, 1.6-2.6; P  .001) and death (AOR, 1.6; 95% CI,
1.1-2.3; P  .006) after surgery. Moreover, the risks of
infectious complications (AOR, 1.6; 95% CI, 1.0-2.1; P 
.001) and pulmonary complications (AOR, 1.6; 95% CI,
1.0-2.1; P  .023) were clearly increased to a significant
degree in symptomatic patients.
DISCUSSION
Several attempts have been undertaken to investigate
the relationship between CEA outcomes and renal func-
tion, but most have been limited, single-institution reports
with relatively small sample sizes, have used serum creati-
nine concentration as a cutoff, and have had conflicting
Table IV. Analysis of negative outcomes risk based on
presence of preoperative neurologic symptoms (stroke or
transient ischemic attack before carotid endarterectomy)
Complication
Asymptomatic,
%
Symptomatic,
%
Overall,
%
Univariate analysis
Neurologic 1.1 2.4a 1.8
Cardiac 1.1 1.3 1.2
Pulmonary 1.1 2.0a 1.5
Infectious 1.4 2.3a 1.8
Death 30 days 0.8 1.6a 1.2
AORb 95% CI P
Multivariate analysis
Neurologic 2.1 1.6-2.6 .001
Cardiac . . . . . . NS
Pulmonary 1.6 1.1-2.4 .023
Infectious 1.6 1.3-2.1 .001
Death 30 days 1.6 1.1-2.3 .006
AOR, Adjusted odds ratio; CI, confidence interval.
aP .001, 2.
bResults of multivariate analysis estimating increased risk in the symptomatic
group versus the asymptomatic group as the reference.results. Debing et al19 examined 102 patients labeled as
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inine clearance 30 mL/min) vs 909 healthy patients,
finding a significantly higher mortality in the CRI group
(3.9% vs 1.0%). Likewise, Ascher et al18 compared 166
patients with renal disease vs 443 healthy subjects and
demonstrated no differences in stroke rate. They did see a
higher mortality rate in those whose creatinine 3.0 mg/
dL, but not necessarily when creatinine was between 1.5
and 2.9 mg/dL. Tarakji et al20 examined 143 patients with
CRI out of 1351 consecutive CEAs. Normal function,
moderate CRI, and severe CRI were defined by creatinine
cutoffs at 1.5 and 3.0 mg/dL. Compared with 150 healthy
patients, they found a markedly increased rate of stroke,
myocardial infarction, and death as renal function wors-
ened.
Conversely, Reed et al10 did a retrospective review of
1370 consecutive CEAs and defined renal insufficiency as a
creatinine level2.0 mg/dL. They found no differences in
stroke rate at all, and no higher risk of death attributable to
renal function alone. The mortality rate was only increased
in patients who had two or more defined risk factors, such
as CHF, COPD, contralateral carotid occlusion, or recent
coronary artery bypass graft surgery. Reil et al21 examined
370 CEAs performed by a single surgeon. They defined
CRI as creatinine 1.5 mg/dL and demonstrated no dif-
ference in stroke or death rates.
The greatest limitation to studies like these is that
serum creatinine levels alone are a late and inadequate
marker of total renal function27 for three main reasons.
First, creatinine is freely filtered by the glomerulus, but
is also secreted by the proximal tubule. Thus, excretion into
urine is a combination of both filtered and secreted creati-
nine rather than filtered alone, erroneously increasing cre-
atinine clearance and systematically overestimating the
GFR. This overestimation ranges from 10% to 40% in
healthy individuals, and can be higher and less predictable
in those with chronic kidney disease.22
Second, creatinine metabolism is variable, depending
on many factors such as age, sex, and race.28 The genera-
tion of creatinine depends on factors like lean muscle mass
and dietary meat or protein intake, whereas the excretion of
creatinine can occur extrarenally through degradation by
bacterial overgrowth in the small bowel. It has been esti-
mated that in patients with chronic kidney disease, as much
as two-thirds of the total daily creatinine excretion occurs
extrarenally.23 As a consequence, up to 40% of those with a
decreased GFR can still have serum creatinine levels within
the normal range for a particular laboratory.
Third, the measurement itself of serum creatinine is
subject to artifact and interference, depending on particular
assays that differ among various laboratories.29 This will
overestimate or underestimate the GFR, depending on the
enzymatic and analytic methods used at different institu-
tions.
In our study, 13,965 patients with adequate (normal or
mildly reduced) renal function (GFR 60 mL/min/1.73
m2 as the cutoff) were compared with 6423 patients with
moderate CRI (GFR 30-59 mL/min/1.73 m2) and 511patients with severe CRI (GFR 30 mL/min/1.73 m2)
but without dependence on dialysis. We did not detect any
statistically significant associations between renal function
and the development of postoperative neurologic compli-
cations, but there was a trend toward increasing risk with a
worsening GFR (Fig).
Because the VA-NSQIP is not a vascular surgery regis-
try, technical aspects of CEA—such as contralateral carotid
artery occlusion, operative technique, or use of patching—
that may have an effect on the rate of neurologic complica-
tions could not be analyzed. Interestingly, contrary to
other studies that have shown no effect on stroke rate from
diabetes mellitus,30 we found adverse neurologic outcomes
were significantly higher in diabetic patients. Even adjust-
ing for other factors, diabetic patients taking oral medica-
tions (AOR, 1.3; 95% CI, 1.0-1.7; P  .04) or requiring
insulin (AOR, 1.5; 95% CI, 1.0-2.1; P  .04) were at
increased risk. Other independent risk factors for neuro-
logic complications were history of TIA (AOR, 1.9; 95%
CI, 1.5-2.3; P  .001) and stroke (AOR, 1.9; 95% CI,
1.5-2.4; P  .001), which we had used to identify symp-
tomatic patients.
Defining patients with symptomatic carotid disease has
been historically inconsistent. NASCET included only pa-
tients with hemispheric TIA, amaurosis fugax, or nondis-
abling stroke 120 days, and excluded those who experi-
enced cerebral infarction that had eliminated useful
function in the affected arterial territory.3 ESCT included
any patient with a carotid lesion who had at least one
transient or mild ischemic vascular event in the distribution
of one or both carotid arteries within the previous 6
months.4 By definition, all of the patients in our study had
a carotid lesion amenable to operation. Thus, we consid-
ered any patient with history of stroke or TIA preopera-
tively to have symptomatic carotid disease. Almost exactly
half of the 20,899 subjects were symptomatic, allowing for
good statistical comparisons between the two groups.
Symptomatic patients had strikingly increased operative
morbidity, higher rates of postoperative neurologic com-
plication, and a greatly increased mortality rate (Table IV).
Wewere able to demonstrate clearly that moderate CRI
is an independent predictor of increased cardiac and pul-
monary complications, but not 30-day mortality or neuro-
logic complications. On the other hand, increased cardio-
pulmonary or neurologic morbidity was not discovered in
those with severe CRI, but mortality was markedly in-
creased in this group (AOR, 2.7). Given the small relative
proportion of subjects comprising the severe CRI group
(2.4%), the increased mortality rate may explain why addi-
tional complications did not develop, and thus, why statis-
tical significance was not reached in the severe CRI group.
Other independent risk factors for cardiac complications
included history of CHF and poor functional status.
Pulmonary complications were independently pre-
dicted by moderate CRI, as well as diabetes mellitus, his-
tory of COPD, smoking, ASA class 4, poor functional
status, and the use of general anesthesia. It is important and
interesting to note that only the patients with severe CRI
cases a
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likely to have been given regional rather than general
anesthesia (P  .03) at the discretion of the surgeons and
anesthesia providers. This effect, along with the higher
mortality rate that was cited, may also help explain why
increased pulmonary complications were not recorded as
often in those with severe CRI compared with the control
group. This implication that anesthesia type may influence
pulmonary outcomes to a greater degree than renal func-
tion after CEA deserves further investigation.
In the development of infectious complications, wors-
ening renal function showed graduated bivariate relation-
ships, with higher incidences as GFR decreased. However,
these were no longer significant after adjustment in the
multivariate model, suggesting a correlation with other
predictive risk factors such as age and functional status.
There were 249 deaths within 30 days, yielding an oper-
ative mortality of 1.2%. The odds were significantly higher
in both the moderate CRI and severe CRI groups on
bivariate analysis, but after adjustment, only GFR 30
mL/min/1.73 m2 remained independently predictive
(AOR, 2.7; 95% CI, 1.6-4.8; P  .001). The effect is
profound, almost independently tripling the odds of death
after CEA. This confirms the findings of other recently
published studies examining renal function and operative
outcomes, when stratified by GFR. Estrera et al31 showed
that preoperative CRI defined by GFR was the most signif-
icant predictor of death during repairs of the ascending and
transverse aortic arch. In a meta-analysis of 31 studies,
Mathew et al32 found that patients with chronic kidney
disease had higher rates of cardiovascular complications and
death in elective noncardiac operations. Their multivariate
analysis of renal dysfunction revealed a strong, indepen-
dent, graded relationship between severity of renal disease
Table V. Percentage of patients experiencing adverse outc
Complication
Functionally independent
Neuro symptoms
absent
Neuro s
pre
D D D
5057 1723 4738
Neuro 1.0 1.6 1.7
Cardiac 0.6 1.5 0.8
Pulmonary 0.7 1.3 1.4
Infectious 0.9 1.3 1.5
Death 0.6 0.8 1.1
Any 2.9 4.4 4.5
GFR,Glomerular filtration rate (mL/min/1.73m2) as defined by the Modifi
patient does not require nursing care or assistant devices for bathing, fee
preoperative TIA or stroke; D, oral medications or insulin for diabetes m
aThis table describes the percentage of patients who experienced an advers
statistically significant in at least two of the multivariate regression analyses f
of interest and then locate the appropriate column. The number at the top of
The number in each row next to an outcome is a percentage. For example, pa
and diabetes mellitus (n  859) experienced a cardiac outcome in 2.1% of(declining GFR) and mortality rates.To permit the reader to determine the risk of worsening
GFR in conjunction with other risk factors, we constructed
Table V using the four risk factors that were statistically
significant in more than one multivariate regression analysis
(eg, pulmonary complications and death). (History of CHF
was significantly associated with cardiac complications and
death, but was excluded from Table V for simplicity.) By
examining renal function (by GFR), functional status (by
independence versus need of assistance), preoperative neu-
rologic symptoms (stroke or TIA), and presence of diabetes
mellitus, Table V provides the reader with the percentage of
patients in the cohort who had an adverse outcome for any
combination of risk factors. These data could be used to
provide an estimate of risk for an individual patient or to
allow surgeons or groups of surgeons to evaluate their rates
of complications against this large cohort with appropriate
adjustment for case-mix. Of course, all of the patients in
this study were determined to be surgical candidates, and
there was no comparison withmedical therapy vs surgery. It
would be inappropriate to use the data from Table V in
isolation of these considerations.
CONCLUSION
We have found that CRI, defined by GFR, significantly
affects outcomes after CEA. Though impaired renal func-
tion alone is not a risk factor for neurologic or infectious
complications, moderate CRI (GFR 30-59 mL/min/1.73
m2) independently increases the risk of cardiac and pulmo-
nary complications, but not death. The operative mortality
rate is much higher in those with severe CRI (GFR 30
mL/min/1.73 m2) compared with those with adequate
renal function. Chronic renal insufficiency should be con-
sidered an independent risk factor for this operation, and
these patients should be carefully evaluated before CEA to
s after carotid endarterectomy, adjusting for risk factorsa
GFR 60
Needs assistance
oms Neuro symptoms
absent
Neuro symptoms
present
D D D D D
1528 130 76 480 232
2.9 1.5 1.3 5.0 4.7
1.1 1.5 1.3 2.5 1.7
1.8 2.3 1.3 1.5 6.0
2.0 0.8 1.3 4.2 6.9
1.6 2.3 4.0 3.1 3.5
6.4 4.6 6.6 10.4 13.4
of Diet in Renal Disease formula (see Methods); Functionally independent,
toileting, dressing, or walking in the previous 30 days; Neuro symptoms,
D, does not require oral medications or insulin for diabetes mellitus.
ome after undergoing carotid endarterectomy. Four risk factors that were
outcomes listed were selected. To use this table, determine the risk factors
olumn indicates the number of patients in the cohort meeting these criteria.
with a GFR of 30 to 59, functional independence, no neurologic symptoms,
nd death in 1.5% of cases.ome
ympt
sent
cation
ding,
ellitus;
e outc
or the
each c
tientsoptimize existing cardiac and pulmonary disease. Under-
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 6 Sidawy et al 1429standing this increased risk may assist the surgeon in pre-
operative counseling and perioperative management.
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